PATENT CLAIM ANALYSIS

Application Number: 16274123
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "001100"]

Abstract:
Provided herein are methods for the production of native and reconstituted hyaluronan (HA) complexes containing pentraxin-3 (PTX3) and heavy chain 1 (HC1) of inter alpha inhibitor (IαI). Compositions containing the complexes and therapeutic methods using the complexes are provided. Combinations and kits for use in practicing the methods also are provided.

Claim (Index 114):
The use of  claim 112  or  claim 113 , wherein the subject has diabetes mellitus type 1.

Metadata:
- Claim Count in Document: 87.0
- Percentile: 99.0
- Lexical Diversity: 1.63158
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14414047', '15214706', '15160487', '13262725', '13782968']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8361324081743875
- 35 USC 102 Novelty (BERT): 0.618532741353074
- Combined Prediction Score: 0.8143724414922562
- Mean Citation Score: 614.755842
- Max Citation Score: 879.9582
- Similarity Product: 489.0160629691243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test